Testing effectiveness (Phase 2)WithdrawnNCT06308575
What this trial is testing
A Phase II Study of Rivoceranib for Patients With Recurrent or Metastatic Olfactory Neuroblastoma
Who this might be right for
Metastatic Olfactory NeuroblastomaRecurrent Olfactory Neuroblastoma
M.D. Anderson Cancer Center